| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |